Coloplast A/S (CLPBY)
12.41
+0.36
(+2.99%)
USD |
OTCM |
May 03, 16:00
Coloplast 1 Year Total Returns (Daily): -12.74% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | -12.74% |
| May 02, 2024 | -13.98% |
| May 01, 2024 | -13.18% |
| April 30, 2024 | -13.16% |
| April 29, 2024 | -10.95% |
| April 26, 2024 | -10.31% |
| April 25, 2024 | -8.60% |
| April 24, 2024 | -5.10% |
| April 23, 2024 | -4.00% |
| April 22, 2024 | -6.25% |
| April 19, 2024 | -3.46% |
| April 18, 2024 | -6.83% |
| April 17, 2024 | -4.15% |
| April 16, 2024 | -3.09% |
| April 15, 2024 | -3.61% |
| April 12, 2024 | -2.10% |
| April 11, 2024 | 1.59% |
| April 10, 2024 | 0.45% |
| April 09, 2024 | 0.14% |
| April 08, 2024 | 0.44% |
| April 05, 2024 | 1.07% |
| April 04, 2024 | 3.67% |
| April 03, 2024 | 5.09% |
| April 02, 2024 | 4.36% |
| April 01, 2024 | 6.48% |
| Date | Value |
|---|---|
| March 28, 2024 | 12.01% |
| March 27, 2024 | 11.10% |
| March 26, 2024 | 12.76% |
| March 25, 2024 | 13.01% |
| March 22, 2024 | 14.82% |
| March 21, 2024 | 15.17% |
| March 20, 2024 | 16.43% |
| March 19, 2024 | 15.43% |
| March 18, 2024 | 16.71% |
| March 15, 2024 | 21.90% |
| March 14, 2024 | 19.29% |
| March 13, 2024 | 24.91% |
| March 12, 2024 | 31.19% |
| March 11, 2024 | 30.00% |
| March 08, 2024 | 28.89% |
| March 07, 2024 | 28.62% |
| March 06, 2024 | 25.61% |
| March 05, 2024 | 21.87% |
| March 04, 2024 | 23.58% |
| March 01, 2024 | 20.85% |
| February 29, 2024 | 19.74% |
| February 28, 2024 | 18.13% |
| February 27, 2024 | 18.43% |
| February 26, 2024 | 21.33% |
| February 23, 2024 | 19.80% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-41.04%
Minimum
Sep 23 2022
61.69%
Maximum
Jun 01 2020
8.70%
Average
9.68%
Median
Sep 27 2023
1 Year Total Returns (Daily) Benchmarks
| Genmab A/S | -27.42% |
| Ascendis Pharma A/S | 49.85% |
| Galecto Inc | -59.76% |
| Evaxion Biotech AS | -69.14% |
| IO Biotech Inc | -24.68% |